Visible-light-triggered prodrug nanoparticles combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy J Choi, MK Shim, S Yang, HS Hwang, H Cho, J Kim, WS Yun, Y Moon, ... ACS nano 15 (7), 12086-12098, 2021 | 103 | 2021 |
Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity S Yang, MK Shim, WJ Kim, J Choi, GH Nam, J Kim, J Kim, Y Moon, ... Biomaterials 272, 120791, 2021 | 94 | 2021 |
Combination of cancer-specific prodrug nanoparticle with Bcl-2 inhibitor to overcome acquired drug resistance J Kim, MK Shim, S Yang, Y Moon, S Song, J Choi, J Kim, K Kim Journal of controlled release 330, 920-932, 2021 | 46 | 2021 |
Doxorubicin-loaded PLGA nanoparticles for cancer therapy: molecular weight effect of PLGA in doxorubicin release for controlling immunogenic cell death Y Choi, HY Yoon, J Kim, S Yang, J Lee, JW Choi, Y Moon, J Kim, S Lim, ... Pharmaceutics 12 (12), 1165, 2020 | 43 | 2020 |
The safe and effective intraperitoneal chemotherapy with cathepsin B-specific doxorubicin prodrug nanoparticles in ovarian cancer with peritoneal carcinomatosis J Kim, MK Shim, YJ Cho, S Jeon, Y Moon, J Choi, J Kim, J Lee, JW Lee, ... Biomaterials 279, 121189, 2021 | 32 | 2021 |
Sustained and long-term release of doxorubicin from PLGA nanoparticles for eliciting anti-tumor immune responses J Kim, Y Choi, S Yang, J Lee, J Choi, Y Moon, J Kim, N Shim, H Cho, ... Pharmaceutics 14 (3), 474, 2022 | 22 | 2022 |
Injectable hydrogel-based combination cancer immunotherapy for overcoming localized therapeutic efficacy J Kim, Y Choi, DH Kim, HY Yoon, K Kim Pharmaceutics 14 (9), 1908, 2022 | 14 | 2022 |
Comparative study of cathepsin B-cleavable linkers for the optimal design of cathepsin B-specific doxorubicin prodrug nanoparticles for targeted cancer therapy N Shim, SI Jeon, S Yang, JY Park, M Jo, J Kim, J Choi, WS Yun, J Kim, ... Biomaterials 289, 121806, 2022 | 12 | 2022 |
Implantable micro-scale LED device guided photodynamic therapy to potentiate antitumor immunity with mild visible light J Choi, IS Lee, JS Lee, S Jeon, WS Yun, S Yang, Y Moon, J Kim, J Kim, ... Biomaterials Research 26 (1), 56, 2022 | 11 | 2022 |
Recent Studies and Progress in the Intratumoral Administration of Nano-Sized Drug Delivery Systems WS Yun, J Kim, DK Lim, DH Kim, SI Jeon, K Kim Nanomaterials 13 (15), 2225, 2023 | 10 | 2023 |
Tumor-specific monomethyl auristatin E (MMAE) prodrug nanoparticles for safe and effective chemotherapy H Cho, MK Shim, Y Moon, S Song, J Kim, J Choi, J Kim, Y Lee, JY Park, ... Pharmaceutics 14 (10), 2131, 2022 | 6 | 2022 |
Micro-syringe chip-guided intratumoral administration of lipid nanoparticles for targeted anticancer therapy J Kim, S Song, M Gwak, H Cho, WS Yun, N Hwang, J Kim, JS Lee, ... Biomaterials Research 27 (1), 102, 2023 | 2 | 2023 |